We are live on ! Find out more
Loomis, Sayles & Company

Loomis, Sayles & Company Portfolio holdings

AUM $74.3B
1-Year Est. Return 24.01%
This Fund
S&P 500
This Quarter Est. Return
+21.9%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$57.6B
AUM Growth
+$7.69B
Cap. Flow
+$3.7B
Cap. Flow %
6.42%
Top 10 Hldgs %
40.22%
Holding
1,054
New
202
Increased
277
Reduced
473
Closed
81

Top Sells

Rank Stock Value
1
NVS icon
Novartis
NVS
+$379M
2
SHW icon
Sherwin-Williams
SHW
+$161M
3
NVDA icon
NVIDIA
NVDA
+$154M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$116M
5
BA icon
Boeing
BA
+$80M

Sector Composition

Rank Sector Weight
1 Technology 26.6%
2 Consumer Discretionary 15.59%
3 Communication Services 15.36%
4 Healthcare 13.38%
5 Financials 10.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COP icon
576
ConocoPhillips
COP
$148B
$52K ﹤0.01%
521
+249
+92% +$27.2K
DOV icon
577
Dover
DOV
$28.3B
$52K ﹤0.01%
339
+208
+159% +$30.5K
MCD icon
578
McDonald's
MCD
$194B
$52K ﹤0.01%
185
-930
-83% -$249K
PPLT
579
abrdn Physical Platinum Shares ETF
PPLT
$2.05B
$51K ﹤0.01%
+5,600
New +$51.4K
TT icon
580
Trane Technologies
TT
$105B
$51K ﹤0.01%
+275
New +$49.9K
AEE icon
581
Ameren
AEE
$29.6B
$50K ﹤0.01%
578
+205
+55% +$17.5K
SHW icon
582
Sherwin-Williams
SHW
$88.1B
$50K ﹤0.01%
223
-701,892
-100% -$161M
WEC icon
583
WEC Energy
WEC
$34.6B
$50K ﹤0.01%
526
+190
+57% +$17.6K
HES
584
DELISTED
Hess
HES
$49K ﹤0.01%
373
+259
+227% +$36.1K
LULU icon
585
lululemon athletica
LULU
$14.5B
$49K ﹤0.01%
134
-58
-30% -$18.2K
FITB
586
Fifth Third Bancorp
FITB
$51.8B
$48K ﹤0.01%
+1,785
New +$59.3K
OKE icon
587
Oneok
OKE
$56.9B
$48K ﹤0.01%
749
+185
+33% +$12.3K
IPG
588
DELISTED
Interpublic Group of Companies
IPG
$47K ﹤0.01%
1,260
+680
+117% +$24.4K
CI icon
589
Cigna
CI
$73.6B
$46K ﹤0.01%
181
+75
+71% +$21.9K
COF icon
590
Capital One
COF
$134B
$46K ﹤0.01%
477
+33
+7% +$3.45K
IIPR icon
591
Innovative Industrial Properties
IIPR
$1.66B
$46K ﹤0.01%
610
-533
-47% -$47.1K
A icon
592
Agilent Technologies
A
$42B
$45K ﹤0.01%
324
+217
+203% +$31.7K
AJG icon
593
Arthur J. Gallagher & Co
AJG
$64.7B
$44K ﹤0.01%
+231
New +$43.8K
DHI icon
594
D.R. Horton
DHI
$41B
$44K ﹤0.01%
452
+257
+132% +$24.5K
IJR icon
595
iShares Core S&P Small-Cap ETF
IJR
$112B
$44K ﹤0.01%
454
-14,160
-97% -$1.42M
RTX icon
596
RTX Corp
RTX
$302B
$44K ﹤0.01%
451
+282
+167% +$27.8K
TJX icon
597
TJX Companies
TJX
$175B
$44K ﹤0.01%
565
+374
+196% +$29.4K
APH icon
598
Amphenol
APH
$207B
$43K ﹤0.01%
1,064
+586
+123% +$23.1K
AVB icon
599
AvalonBay Communities
AVB
$26.3B
$43K ﹤0.01%
253
+182
+256% +$31K
NOC icon
600
Northrop Grumman
NOC
$82.1B
$43K ﹤0.01%
93
-40
-30% -$18.6K

Similar funds

Loomis, Sayles & Company's Q1 2023 Portfolio in Review

As of Q1 2023, Loomis, Sayles & Company held 1,054 positions worth $57.6B, up 15% from $49.9B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Loomis, Sayles & Company deployed $3.7B of net new capital in Q1 2023, opening 202 new positions and adding to 277 existing holdings. Its largest new stake was Bank of America Series L: 2,835,020 shares worth $81.1M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was Novartis, an estimated $379M trimmed.

  • Loomis, Sayles & Company's largest Q1 2023 buy was Bank of America Series L: 2,835,020 shares worth $81.1M.
  • Loomis, Sayles & Company added most to Tesla in Q1 2023, an estimated $252M increase.
  • Loomis, Sayles & Company's biggest Q1 2023 reduction was Novartis, cutting an estimated $379M.
  • Loomis, Sayles & Company fully exited Globus Medical in Q1 2023, selling an estimated $38M.
  • Loomis, Sayles & Company's ten largest holdings make up 40% of its $57.6B portfolio in Q1 2023.
  • Loomis, Sayles & Company opened 202 new positions and closed 81 in Q1 2023.
  • Loomis, Sayles & Company's portfolio value rose 15% quarter-over-quarter to $57.6B.

Based on Loomis, Sayles & Company's 13F filing for Q1 2023, filed 11 May 2023.